Sageworth Trust’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
Sageworth Trust's HCAT Position: Q1 2022 in Review
Sageworth Trust sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 460 shares — an estimated $18K sold.
Sageworth Trust first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $111K in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.
- Sageworth Trust reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
- Sageworth Trust sold 460 Health Catalyst shares in Q1 2022, an estimated $18K.
- Sageworth Trust first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
- Sageworth Trust's Health Catalyst position peaked at $111K in Q2 2021.
- 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.
Based on Sageworth Trust's 13F filing for Q1 2022, filed 6 May 2022.